Notice: Passwords are now case-sensitive
Forgot your password? Register a new account



Community Requests

Workers' Compensation News


Goldstein: Zero MSAs: What's All the Chatter About? 11/02/2016
State: NA | Segment: Top | 627 | 0
Over the last several weeks, the Medicare Set-Aside community has been astir with all of the forthcoming Centers for Medicare and Medicaid Services changes — from a new CMS review contractor, to possible threshold changes, to the expansion of review for liability MSAs, and now, to the lates...Read More

Gavin: The Broken Disability Safety Net 10/27/2016
State: NA | Segment: Top | 464 | 0
Much has been said and written on the topic of the recent report from the U.S. Department of Labor regarding the supposed inadequacy of the workers' compensation system. Critics rightly point out that the report appears to reduce its own credibility by failing to exhibit a sufficient understa...Read More

Gavin: The Guts to Buck the Lobbyists 10/10/2016
State: NA | Segment: Top | 661 | 0 | Popular with Legal
Ohio has proposed something novel: Let's not pay for expensive naloxone prescriptions and instead invest resources in ensuring the delivery of appropriate medical care and provide help for those struggling with dependence and addiction.  ...Read More

Gavin: The Solution to Every Health Care Debate: Access vs. Cost 09/30/2016
State: NA | Segment: Top | 740 | 0 | Popular with Legal
Two things you need to know about Suboxone (or buprenorphine) highlight the essential elements of all past, present and future health care debates.  ...Read More

Gavin: Bad Pharma: This Is What We're Up Against 09/20/2016
State: NA | Segment: Top | 966 | 0 | Popular with Legal
We all know that lobbyists exist. We all know the role they play in American politics, however frustrating that fact might be to us. We all know that pharmaceutical companies have plenty of them, and they appear to be pretty good at their jobs.  ...Read More

Gavin: FDA and Off-Label Drug Use: Danger Ahead 09/13/2016
State: NA | Segment: Top | 313 | 0
The Food and Drug Administration has scheduled hearings for November (and a public comment period that will extend to January) regarding the agency's current approach to the marketing of off-label uses of FDA-...Read More

Gavin: Health Literacy and Pain Management: How to Do Patient Education 08/17/2016
State: NY | Segment: Top | 511 | 0
Whether or not opioid pain medication might actually worsen pain is a legitimate clinical discussion and an important claims management topic. While the phenomenon is researched and written about in medical journals, talked about at various conferences and acknowledged among physicians, I ha...Read More

Gavin: Nuance Is Necessary in the Naloxone Debate 08/08/2016
State: NA | Segment: Top | 514 | 0
American Medical Association white paper headline: "Help save lives: Increase access to naloxone" New York Times headline: "Naloxone Saves Lives, but Is No Cure in Heroin Epidemic" ...Read More

Gavin: What Will $180 Million Buy Us? 08/01/2016
State: NA | Segment: Top | 288 | 0
The U.S. Senate in mid-July voted 92-2 to pass a piece of legislation, one already passed by the House 407-5. Can you remember the last time you saw a vote tally like that in Congress?  ...Read More

Gavin: Lawmakers Dictate to Doctors: New Legislative Approaches to Opioids 07/14/2016
State: NA | Segment: Top | 325 | 0
Amidst all the talk of seven-day initial opioid script limits in New York, Massachusetts and New Hampshire (with New Jersey, Connecticut and others likely not far behind), we appear to have missed a piece of legislation that, in my view, represents the single most stringent legal construct f...Read More
103 Results Page 5 of 11